Bloomberg’s Mark Gurman reports that Tim Millet has taken over Apple’s secretive division exploring noninvasive blood glucose monitoring. Millet is currently Apple’s VP of platform architecture and was an important figure in transitioning from Intel chips to Apple Silicon.

That said, I would take any news of progress toward noninvasive blood glucose monitoring on the Apple Watch (or any wearable!) with several grains of salt. I did a deep dive into this topic earlier this year and after speaking with a few experts in the field, this tech is still quite a ways off from ever reaching consumers.